SANOFI INDIA launches Combiflam Plus

Ludhiana, February 21, 2013: Sanofi India Limited (previously known as Aventis Pharma Limited) announced today the launch of Combiflam Plus, a targeted, fast and effective solution for headaches, which is also gentle on the stomach. Combiflam Plus is a combination of paracetamol and caffeine. A line extension of one of Sanofi India's flagship brands Combiflam, the launch of this new product marks the company's foray into the OTC headache segment in India.

While announcing the launch, Anindya Chowdhury, Senior Director- Consumer Healthcare, Sanofi India said, "Today's hectic and stressful lifestyles are impacting the quality of life and productivity of people. Data suggests that over 70% of men and women experience an episode of headache every month, and 36% suffer from it weekly.

“We are pleased to introduce Combiflam Plus (a paracetamol and caffeine combination) to our consumers which is a targeted solution for headaches. This combination is shown to have 89% incremental analgesic effect (in terms of total pain relief) when compared with paracetamol monotherapy", he said.

Further, he said Caffeine has been shown to have a synergistic and well documented adjuvant action when combined with analgesics (painkillers). Research shows that adding caffeine to an analgesic for e.g. paracetamol, increases the potency of the analgesic by approximately 40%, he revealed.

He further said Combiflam Plus (paracetamol and caffeine combination) is a targeted, fast and effective solution for headaches, which is also gentle on the stomach.

A study assessing total pain relief with the paracetamol and caffeine combination suggested an 89% incremental analgesic effect when compared with Paracetamol monotherapy.

In a first of its kind 'Pack of 4s' packaging in the headache category, Combiflam Plus is priced at Rs 9.50 (MRP) and will be available in the states of Uttar Pradesh, Maharashtra, Tamil Nadu, West Bengal, Punjab and Haryana .

Chowdhury said Combiflam Plus is a line extension of Combiflam, which has been a trusted brand in the Indian pharmaceutical market for over 25 years, and is present in '1 in every 3 households across India'.